DNA methylation is a key epigenetic modification involved in gene regulation whose contribution to 2 disease susceptibility remains to be fully understood. Here, we present a novel Bayesian smoothing 3 approach (called ABBA) to detect differentially methylated regions (DMRs) from whole-genome bisulphite 4 sequencing (WGBS). We also show how this approach can be leveraged to identify disease-associated 5 changes in DNA methylation, suggesting mechanisms through which these alterations might affect disease. 6
One of the most important epigenetic modifications directly affecting DNA is methylation, where a 2 methyl group is added to a cytosine base in the DNA sequence creating 5-methylcytosine. High-3 throughput sequencing techniques, such as whole-genome bisulphite sequencing (WGBS), now allow for 4 genome-wide methylome data to be collected at single base-resolution (Harris et al. 2010 ). However, the 5 challenge remains on how to accurately identify DNA methylation changes at the genome-wide level and 6 also account for the complex correlation structures present in the data. Whilst it is still not fully 7 understood how DNA methylation affects gene expression, it has been shown that depending on the 8 location of the modification it can either have a positive or negative effect on the level of expression of 9 genes (Gutierrez-Arcelus et al. 2013). How methylation patterns are regulated is complex and a full 10 understanding of this process requires elucidating the mechanisms for de novo DNA methylation and 11 demethylation, as well as the maintenance of methylation (Chen and Riggs 2011) However, the majority of 12 functional methylation changes are found in methylation sites where cytosines are immediately followed 13 by guanines, known as CpG dinucleotides (Ziller et al. 2011 ). These are not positioned randomly across 14 the genome but tend to appear in clusters called CpG islands (CpGI) (Deaton and Bird 2011) . It has been 15 also shown that there are concordant methylation changes within CpGI and in the genomic regions 16
immediately surrounding CpGI (also known as CpGI shores or CpGS). These "spatially correlated" DNA 17 methylation patterns tend to be more strongly associated with gene expression changes than the 18 methylation changes occurring in other parts of the genome (Gutierrez-Arcelus et al. 2015) . The 19 correlation of methylation levels between CpG sites is also highly dependent on their genomic context, 20
varying greatly depending on where in the genome they are located (Zhang et al. 2015) . For 21 computational convenience, the dependence of methylation patterns between CpG sites is sometimes 22 ignored by methods for differential methylation analysis. Alternatively, a simplified estimation of the 23 correlation of methylation levels between neighbouring CpG sites (Bell et al. 2011 ) based on a user-24 defined parameterization of the degree of smoothing is introduced. These strategies might not be 25 appropriate across different experimental scenarios and instead we propose an automatic probabilistic 26 smoothing procedure of the average methylation levels across replicates (hereafter methylation profiles). 27
Beyond the initial univariate analysis of methylation changes at each individual CpG (for instance, 28
using the Fisher's exact test), recently the focus has shifted to identifying differentially methylated regions 29 (DMRs), since coordinated changes in CpG methylation across genomic regions are known to impart the 30 strongest regulatory influence. To this aim, a number of tools have been proposed to detect DMRs from 31 WGBS data. Typically, these methods normally take one of two approaches: Either model the number of 1 methylated/unmethylated reads using a binomial, negative-binomial distribution or discrete distributions 2 with an over-dispersion parameter) such as MethylKit (Akalin et al. 2012) , MethylSig (Park et al. 2014) 3 and DSS (Feng et al. 2014) . Alternatively in order to account for the correlation of methylation profiles 4 between neighbouring CpG sites, a smoothing operator is applied in tools like BSmooth (Hansen et al. 5 2012), BiSeq (Hebestreit et al. 2013 perform generally well in practical applications. However, their results and the identification of the DMRs 8 depend on the choice of the smoothing parameters values, e.g., window size or kernel bandwidth, a 9 feature that makes them less general and prone to perform unequally when the default parameters values 10 are changed. In these cases, smoothing parameters tuned by time-consuming sensitivity analysis based on 11 different parameterizations is usually recommended, although this strategy is rarely applied in real data 12
analyses. Other approaches, e.g., metilene (Jühling et al. 2015) , propose segmentation algorithms to detect 13
DMRs between single/groups of replicates without making any model assumption about the data 14 generating mechanism and less dependent on the parameters definition. Furthermore, several other 15 algorithms have been introduced, e.g., MOABS (Sun et al. 2014 ), Lux (Äijö et al. 2016) , and MACAU (Lea et 16 al. 2015) , showing that bisulfite sequencing data analysis is an active area of research. 17
To address this dependence on parameterization and the subsequent lack of generality, we propose a 18 fully Bayesian approach, approximate Bayesian bisulphite sequencing analysis (or ABBA), designed to 19 smooth automatically the underlying -not directly observable -methylation profiles and reliably identify 20
DMRs whilst borrowing information vertically across biological replicates and horizontally across 21 correlated CpGs ( Fig. 1) . We highlight that this fully Bayesian specification is not adopted by previous 22 DMR detection techniques, owing to the computational overhead of the inferential procedure. We address 23 the high computational demands by utilizing a highly efficient inferential tool (Rue et al. 2009 
) for 24
Bayesian models (see below and Methods). To demonstrate the benefits of adopting ABBA over existing 25 approaches, we report a comprehensive simulation study where we benchmarked ABBA against five 26 commonly used alternative methods (Fisher Exact Test, BSmooth, MethylKit, MethylSig, DSS) and 27 considered a proposed new one (metilene) and assessed the effect of a different biological and 28 experimental conditions (by varying parameters related to data integrity and quality of the signal) on the 29 performance of each method. The results from this benchmark clearly indicate that ABBA is the best 30 performing method, being both robust to changes in factors affecting data quality (e.g., sequencing 31 coverage, errors associated with the methylation call) and level of noise in methylation signal. To 32 benchmark our proposed method on a real dataset, we generated new WGBS data in macrophages from 1 an established rat model of glomerulonephritis (Aitman et al. 2006 ) and control strain, and used ABBA for 2 the genome-wide identification of DMRs. An additional comparison performed with the best alternative 3 method (that arose from the simulation study) showed that ABBA has increased power to detect changes 4 in DNA methylation involving genes and pathways relevant to glomerulonephritis. Furthermore, this 5 comparison exemplifies how the DMR results obtained by alternative approaches depend heavily on the 6 choice of relevant smoothing parameters (e.g., window size used in DSS). We also integrated the DMR 7 results of ABBA with transcription factor binding site analysis, RNA-seq and ChIP-seq data generated in 8
the same system, and in this we revealed a previously unappreciated role for the Ifitm3 gene in the 9 pathogenesis of glomerulonephritis, providing a proof of concept for real data applications of the ABBA 10 approach. 11 When a single replicate is available, since ! ! = 0, (4) and (5) simplify to 17
12

MATERIALS AND METHODS
While some methods for DMR detection (Feng et al. 2014; Wu et al. 2015) , allow for over-dispersion by 20 assuming a beta-binomial model, (4) and (5) imply a logistic-normal model. After integrating out (6), 21
, it can be shown that 22
where !" ≡ exp !" /(1 + exp ( !" )). The above equation illustrates that a priori the marginal degree of 25 variability per CpG site under ABBA model is the variance of the binomial model multiplied by an over-26 dispersion factor that depends on the combined effect of ! ! , the replicates variability, and !" ! , the 27 variance of the unobserved methylation profile. When a single replicate is available, the over-dispersion 1 depends only on !" ! . 2 ABBA algorithm. The ABBA algorithm consists of two steps: the marginal posterior of the unobserved methylation profile !" | is obtained by using the inverse 8 logit transformation of !" , ≡ exp logit / 1 + exp logit . 9
Global differential methylation and FDR calculation. ABBA inference about DMRs is based on the 10 posterior methylation probability (PMP) !" | and the posterior differential methylation probability 11
The posterior mean methylation probability E !" | summarizes the 12 information contained in the PMP and it is used to define the posterior mean differential methylation 13 between two groups, ! = E !! | − E !! | . Once the LGF has been integrated out by INLA inferential 14 process, !" | , = 1, ⋯ , , and in turn ! s become marginally independent. This allows the 15 straightforward application of a non-parametric false discovery rate (FDR) procedure without the burden 16 of correlated signals. To distinguish between the null distribution (no differential methylation) and the 17 alternatives, we fit a mixture of three truncated normal densities 18
where N [!!,!] is a normal density truncated between [−1,1], ! , ! , ! ∈ 0,1 with ! + ! + ! = 1 are 20 the mixing weights of the "negative" differentially methylated, no differentially methylated and "positive" 21 differentially methylated with respect the control group, respectively, ! , ! , ! are the unknown centers 22 of the differentially methylated groups and ! ! , ! ! , ! ! are the unknown variances. Under the null 23 hypothesis we set ! = 0. For identifying the components of mixture model we also impose the condition 24 ! ≥ ! + ! under the assumption that the large majority of CpG sites are not differentially methylated. 2009, the non-null distribution ! can have more than two components. This allows a better fitting of the 28 tails of distribution of ! 's and the identification of more than two differentially methylated groups. For 29 instance the choice of the number of components can be based on Bayesian Information Criterion (BIC). 1
However this requires running the FDR procedure several times for each choice of the number of 2 components. Another possibility which is less computational intensive relies on the approximation of ! 3 by using a non-parametric Gaussian kernel density estimation (Kuan and Chiang 2012). 4
Maximum likelihood estimates of (9) are obtained by the EM algorithm (Dempster et al. 1977) taking 5 particular care to avoid local maxima in the likelihood surface by running the EM algorithm from different 6 starting points. Using the EM algorithm, the posterior probability of a CpG site belonging to each of the 7 three component is 8
Similarly to Broët et al. 2004 , for a constant , we define the estimated FDR as 13
where ℐ ! = : ! ≤ − , ℐ ! = : ! ≥ , ! = # ℐ ! and ! = # ℐ ! . (10) defines the global FDR as the 15 average local FDR which, for posterior probabilities, is defined as 1 − P ! = " − " − P ! = " + " = 16 P ! = "0" . Finally the constant is chosen such that FDR ≤ FDR. 17
In summary, the FDR procedure for ABBA consists of two steps: 18 1. Fit a mixture of truncated normal densities with three components on the ! s values; obtain the 19 posterior probability that each ! belongs to each of the three components; 20 2. Calculate the constant such that FDR ≤ FDR for a desired level of FDR; 21
For computational efficiency our FDR procedure can be run on each chromosome separately and then the 22 results can be aggregated at the genome-wide level (Efron 2008) . Besides the computational speed, this 23 strategy does not assume the existence of a global methylation level difference between the two 24 conditions that may not hold in practice. The separate-class model (Efron 2008) , can be used to combine 25 separate chromosome-wide FDRs. 26 WGBS data simulation. WGBS data have a number of intrinsic characteristics that can vary depending on 1 the cell-types/tissue complexity being studied or on technical issues related to the sequencing. In order 2 assess which method is the most robust for analyzing WGBS data it is important that changes in each of 3 these characteristics are taken into account. Here we take advantage of our previously published WGBS-4 data simulator (Rackham et al. 2015 ) that allows us to generate unbiased benchmarking datasets with 5 several varying parameters. Wherever possible we will refer to the notation used in Rackham et al. 2015; 6 the parameters are the following: 7
1. Number of replicates -the parameter was set to vary between = 1,2,3 within each group; 8 2. Average read depth -at each CpG site for all replicates and groups, the number of reads !"# , 9 = 1, ⋯ , and = 1,2, is simulated using a Poisson distribution with average read depth . The 10
parameter was set to be either 10 or 30 reads on average per CpG site; 11
3. Level of noise -the parameter ! controls the level of noise added the probability of methylation at 12 each CpG site for all replicates and groups and simulates the measurement error resulting from the 13 sampling of DNA segments during sequencing 14
where !" is the global probability of methylation of the binomial (emission) distribution based on 16 difference" controls the magnitude of the difference between the probabilities of methylation in each 22 group and was set to vary between 20%, 30%, 50% or 70%. This difference is obtained on CpG sites 23
where both case and control samples share the same methylated status (methylated or 24 unmethylated), by adding a given value to the probability in either cases or controls. The total length 25 of the sequence where this difference appears in no greater than 5% (WGBSSuite default value) of the 26 total length of the simulated region. 27 5. We also considered an additional parameter (not available for modeling in WGBSSuite), which 28
introduces a further error associated with the methylation call. After selecting at random with a given 29 probability a CpG site in the th group for all replicates, we switch its methylation status between 30 the two groups. In our simulation study, the parameter has been varied from 0, 0.05 and 0.1. 31
To perform the benchmarking we generate 5 replicates of 5,000 CpGs for each combination of the 1 above parameters. The resulted in a total of 216 benchmarking datasets (3 cases for the number of 2 replicates, 2 cases for the average read depth, 3 cases for the level of noise, 4 cases for the methylation 3 probability difference, 3 cases for the parameter ) which are replicated 5 times (5,400,000 CpGs in total) 4 to assess the Monte Carlo average performance for each combination of parameters. In these datasets the 5 size of the differentially methylated regions has a median size of 15 CpGs (see Supplementary Figure 3 ). 6
The proportion of differentially methylated CpGs cannot exceed 20% of all CpGs (i.e., ~1000 CpGs). 7
Receiver operator curve (ROC) construction for benchmarking. In order to generate the ROC curve 8 the performance is calculated CpG-wise. For a given DMR, detection of each of the CpG contained within is 9 considered as a true positive, whilst CpGs that are not detected are considered false negatives. Outside of 10 the DMR the opposite criteria is applied. We choose this assignment criteria rather than calling detection 11 of a each DMR since it provides a useful quantification of the extent each DMR is captured by each 12 technique, for instance if one technique correctly identifies all the CpGs in a DMR, the method is deemed to 13 perform better than an approach that identifies correctly only 80% of the CpGs within the same DMR. 14 WGBS data pre-processing for ABBA. To run ABBA efficiently at the genome-wide level we took 15 advantage of cluster-computing environment that enables parallel computation, and to this aim we 16
preprocessed the WGBS data as follows. After the raw WGBS data were aligned, we removed CpG sites 17
where less than 50% of the samples contain reads. Next, we split the WGBS data into chunks such that the 18 distance between the last CpG site in one chunk and the first CpG in the next chunk is greater than 19 3,000bp. It has been previously shown that the correlation of DNA methylation levels between CpG sites 20 decreases dramatically after 400bp (Zhang et al. 2015) , so splitting the data in this way implies a 21 particular conditional dependence structure in our data defined by a sparse block-diagonal precision 22 matrix ( ) where each block corresponds to a WGBS chunk. Chunks are then analyzed in parallel in a 23 cluster-computing environment. We calculated the time required by ABBA to analyse chunks of different 24 length (that span from 100 CpGs to 15,000 CpGs) on a single machine with 20 2.3GHz hyper-threaded 25 cores and 32GB of RAM and found that the computational time (seconds) scales with the chunk length 26 (NCpG, number of CpG sites) following the power function: time (seconds) = 0.0045 NCpG 1.3985 (R² = 0.997). 27
Depending on the genome length and data dimensionality a complete WGBS analysis ABBA might require 28 days (e.g., it took ~2 weeks to analyse WGBS data in the rat). The total computational time of ABBA 29 analysis can be significantly shortened by splitting the genome into smaller chunks and then assemble the 30 result. The results provided by the "whole-genome" ABBA analysis and "smaller-chunks" ABBA analyses 31 are highly consistent, with no differences in the distribution probabilities obtained with and without 1 splitting the genome in chunks (Supplementary Figure 4) . Scripts for the pre-processing step are 2 embedded within ABBA at abba.systems-genetics.net 3 WGBS of rat macrophages. Bone-marrow derived macrophages (BMDM) were isolated from WKY and 4 LEW rat strains. WGBS libraries were produced as follows: 6μg of genomic DNA was spiked with 10ng of 5 unmethylated cl857 Sam7 lambda DNA (Promega) and sheared using a Covaris System S-series model S2. 6
Sheared DNA was purified and then end-repaired in a 100μl reaction using NEBNext End Repair kit (New 7
England Biolabs) incubated at 20C for 30 minutes. End-repaired DNA was next A-tailed using NEBNext 8 dA-tailing reaction buffer and Klenow Fragment (also New England Biolabs) incubated at 37C for 30 9 minutes and then purified with the MinElute PCR purification kit (Qiagen) in a total final elution volume of 10 28μl. Illumina Early Access Methylation adapter oligos (Illumina) were then ligated to a total of 25μl of the 11
A-tailed DNA sample using NEBNext Quick Ligation Reaction Buffer and Quick T4 DNA ligase (both New 12
England Biolabs) in a reaction volume of 50μl. This mixture was incubated for 30 minutes at 20C prior to 13 gel purification. Bisulphite conversion of 450ng of the purified DNA library was achieved using the Epitect 14
Bisulfite kit (Qiagen) in a total volume of 140μl. Samples were incubated with the following program: 95C 15 for 5 minutes, 60C for 25 minutes, 95C for 5 minutes, 60C for 85 minutes, 95C for 5 minutes, 60C for 175 16 minutes and then 3x repeat of 95C for 5 minutes and 60C for 180 minutes and held at 20C. Treated 17 samples were then purified as per manufacturers instructions. Adapter bound DNA fragments were 18 amplified by a 10-cycle PCR reaction and then purified using Agencourt AMPure XP beads (Beckman 19
Coulter) before gel extraction and quantification using the Agilent Bioanalyzer 2100 Expert High 20
Sensitivity DNA Assay. Then, libraries were quantified using quantitative PCR and then denatured into 21 single stranded fragments. These fragments were then amplified by the Illumina cluster robot and 22 transferred to the HiSeq 2000 for sequencing. WGBS reads were aligned and filtered according to a 23 previously published pipeline (see (Johnson et al. 2012 ) and (Johnson et al. 2014) ). Briefly, reads were 24 pre-processed by in silico conversion of C bases to T bases in read 1 and G bases to A bases in read 2, 25 followed by clipping of the first base from each read. Pre-processed reads were aligned to the rat 26 reference genome (RGSC3.4) using BWA version 0.6.1 (Li and Durbin 2009) with 3' end quality trimming 27 using a Q score cutoff of 20. Converted and clipped reads 1 and 2 were mapped to two in silico converted 28 versions of the reference sequence, firstly with Cs converted to Ts to allow forward strand mapping, and 29 secondly with Gs converted to As to allow mapping of reverse strand. Aligned reads were filtered by 30
removal of clonal reads, reads with a mapping quality of <20, reads that mapped to both in silico 31 converted forward and reverse strands, and reads with an invalid mapping orientation. We obtained 79. 9 32 billion 'mappable' bases across both rat strains, with 13.5x (average) coverage in the Lew strain and 17.6x 1 (average) in WKY, where the greatest depth of coverage was observed within CpG islands. 2
Despite ABBA being able to detect methylation changes at all genomic locations we focused only on 3 those methylation changes that occur at CpG sites, and considered CpG sites where at least 4 out of the 8 4 samples contain reads (resulting in a total of 14,976,632 CpG sites genome-wide in BMDM from WKY and 5 LEW rats). DMRs were called with ABBA (see above) using a 5 CpG minimum, a 33% or greater difference 6 in methylation and a 5% FDR threshold. Genomic region annotations and Ensembl gene IDs for the rat 7 reference genome 4 (rn4) were downloaded from the UCSC genome browser. Significant over- here. Briefly, total RNA was extracted from BMDM at day 5 of differentiation in three WKY rats and three 20 LEW rats using Trizol (Invitrogen). 1 μg of total RNA was used to generate RNA-seq libraries using TruSeq 21 ChIP-seq data from BMDM isolated from the WKY and WKY.LCrgn2 congenic strains (in which the LEW 1
Crgn2 QTL was introgressed onto the WKY background) were retrieved from (Hull et al. 2013 ; Srivastava 2 et al. 2013 ) and re-analyzed with respect to the Ifitm3 locus. This congenic model (WKY.LCrgn2) has been 3 extensively studied in previous studies where it has been shown that JunD expression levels are 4 significantly higher in WKY when compared with the congenic (Hull et al. 2013 ) and that the canonical 5 binding of AP-1 is significantly greater in WKY compared to WKY.LCrgn2 (Behmoaras et al. 2008 ). Briefly, 6
ChIP was performed with a JunD antibody (Santa Cruz sc74-X) and a negative IgG control (sc-2026). Single 7 read library preparation and high throughput single read sequencing for 36 cycles was carried out on an 8
Illumina Genome Analyser IIx and sequencing of the ChIP-seq libraries was carried out on the high 9 throughput Illumina Genome Analyzer II. Initial data processing was performed using Illumina Real Time 
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We employ a fully Bayesian approach (a Bayesian structured generalized mixed additive model with a specified FDR by contrasting PMPs across the whole-genome between two groups, e.g. cases and controls. 8
Several intrinsic features of WGBS data are incorporated into ABBA: for instance, the variability in DNA 9 methylation between the (experimental) replicates within each group is modeled through a random effect 10 with a specific within-group variance (Fig. 1a) . The correlation of DNA methylation patterns is encoded in 11 the latent Gaussian field equation, which reflects the neighborhood structure of the model and 12
automatically adapts to the changes in the underlying data. In particular, the a priori correlation between 13 neighbouring CpGs' methylation profiles depends on the distance between them, as it decreases as this 14 distance increases (Fig. 1b) . Rather than relying on a user-defined value to parameterize it (e.g., kernel 15 bandwidth or window size) or fixing it by an automatic procedure (for instance through an empirical 16
Bayes approach), ABBA assigns a prior distribution on the parameters of the latent Gaussian field 17 equation, thus fully accounting for the uncertainty about these quantities. This specification is key in our 18 model since the data-adaptivity of the degree of smoothing conforms better to the data than assuming 19 fixed values. All these features allow our model to adjust routinely to real-world scenarios, providing an 20 automatic way to describe the WGBS data without requiring any user-defined parameters (Yu and Sun test (FET)). All methods were run using their default parameterization and for the FET we pooled data 26 from different replicates. To ensure a fair comparison, we used WGBSSuite (Rackham et al. 2015) to 27 generate a large number of diverse datasets that were independent of the underlying statistical models of 28 ABBA and of the other methods. Briefly, we simulated in-silico datasets to assess the performance of each 29 method under several scenarios, which reflect differences in data integrity and quality of the signal that 30
can occur as a result of biological and experimental phenomenon. The parameters considered were the 31 following: the number of replicates within each group ( ), the average read depth per CpG, the level of 1 noise variance ( ! ), the methylation probability difference between the two groups (Δmeth) and the 2 switching of methylation status of CpG sites between the two groups ( ) (see Methods for details). For 3 each simulated case we generate five replicates and we compared the accuracy of the CpGs called as being 4 contained within DMRs by each technique with the true simulated DMRs. To quantitatively assess the 5 performance of ABBA with respect to competing methods, we evaluated false-positive and false-negative 6 rates of CpG sites and generated receiver operator characteristic (ROC) curves. We focus on the partial 7 area under the ROC curve (or pAUC) at a specificity of 0.75. The pAUC is considered to be more practically 8 relevant than the area under the entire ROC curve (Ma et al. 2013 ) since in typical genomics studies only 9
the features identified at very low false positive rates are selected for further biological validation. 10
All results of the benchmark are detailed in Supplementary Figures 5-7 . In Fig 2a we show  11 representative ROC curves from a specific combination of parameters whilst in Fig. 2b we summarize the 12 performance over all combinations of parameters by displaying the best performing method based on its 13 pAUC. Specifically, in Fig. 2b the color code in the "benchmark grid" indicates the best performing method 14 for each of the 216 simulated scenarios. For instance, in Fig. 2a approach, which shows that ABBA is the best performing method. Accordingly, in Fig. 2b the square in the 18 grid that represents this parameter set (indicated by (i) in the figure) is coloured black (ABBA). Examples 19 of other ROC curves for specific combinations of parameters are reported in Fig. 2a (i-vi) and the 20 corresponding best performing methods are indicated in Fig. 2b . In some simulated cases (e.g., with high 21 levels of = 10%) the ROC curves and corresponding pAUC do not distinguish unambiguously the best 22 performing method (e.g., Fig. 2a -panel (vi) ). In these cases when the pAUC of two methods are very 23 similar (±1%) we report the colours of both methods, e.g., black and red colours in the same square to 24 indicate similar performance of ABBA and DSS (Fig. 2b) . For the metilene approach (Jühling et al. 2015) 25
(which was run using its default parametrization) we noticed that ROC curve analysis was not suitable to 26 compare its perfomance with other methods. Specifically, for metilene we found that it was not possible to 27 assess both specificity and sensitivity across the wide range of DMRs and scenarios simulated in our 28
study. Representative examples for the ROC curves obtained by running metilene (and other approaches) 29
on the simulated data are provided in Fig. 2a and in Supplementary Figure 8 . 30
Considering all 216 simulated datasets and comparing the pAUCs obtained by each approach across all 1 combinations of parameters, ABBA (black) showed to be the best performing method in 139 (64%) cases 2 ( Fig. 2b-c) . The two other competitive methods were DSS and BSmooth, which show to be the best 3 performing approach only in 26 (12%) and 22 (10%) simulated cases, respectively (Fig. 2b-c) . In 28 4 (13%) cases different methods showed very similar performance (i.e., pAUCs ±1%), and in 17 simulations 5 ABBA and DSS showed to have comparable performance. Looking at the detailed ROC curves reported in 6 Supplementary Figures 5-7 , we notice that while ABBA was the best method across all simulations ( Fig.  7   2c) , its performance diminished for simulated datasets with very small methylation probability difference 8 between the two groups. In particular, for most of the simulated scenarios with Δmeth = 20%, BSmooth 9
showed very good and robust performance, while DSS was consistently the best performing method when 10 r = 1 and Δmeth = 20%, Fig. 2b . However, we highlight that such small differences in DNA methylation 11 (i.e., Δmeth ≤ 20%) are unlikely to have an important biological effect, and the most commonly observed 12 effect sizes for DMR range between 20 and 40%, as previously reported (Ziller et al. 2015) . In the range 13
Δmeth ≥ 30%, ABBA was the best performing method in 132 (81%) simulations, while DSS was the best 14 performing method only in 10 (6%) simulated cases and, notably, BSmooth was never the best single 15 performing method (BSmooth showed similar performance of ABBA in only one simulated case) ( Fig. 2b) . 16 Specific observations have to be addressed when high levels of errors due to the switching of 17 methylation status of CpG sites between the two groups have been simulated. In these scenarios, it was 18 more difficult to single out a method that outperforms all competing approaches. However, when was as 19 high as 10% (i.e., 1 in 10 CpGs is misclassified as unmethylated or vice versa), we observed that ABBA was 20 the best single method in 33 (46%) of 72 simulated scenarios, whereas DSS and BSmooth performed as 21 the best method in 16 (22%) and 7 (10%) of cases, respectively, and in other 10 cases ABBA and DSS have 22 comparable performance. The latter was more apparent when large probability differences between the 23 two groups were simulated (Δmeth = 50% or 70%). 24
We then explored whether non-homogeneous, spatially correlated read depth has an effect on ABBA's 25 performance. In order to capture spatially correlated read depth from real data we sampled 5,000 26 contiguous CpGs from WGBS data (generated in rat macrophages, see below and Methods for details) and 27 then varied other parameters ( and Δmeth) using WGBSSuite as described above. In these "data-derived" 28 simulated datasets the read depth was correlated with the distance between CpGs (Supplementary  29   Figure 9a ). The results of the benchmark using read depth taken from real data were very similar to those 30 obtained using read depth simulated by means of a Poisson distribution (see Methods). Regardless of 31 whether "data-derived" or "Poisson-simulated" read depth was used in our simulations, ABBA was the 1 best performing method to recall DMRs (representative examples are reported in Supplementary Figure  2   9b ). While heterogeneous levels of read depth impact on the single base probability of methylation, the 3 hierarchical model underlying ABBA borrows information across the sequence analyzed, it turns out that 4 ABBA posterior estimates are less sensitive to different levels of the read depth. 5
Taken together our simulation study shows that while individual approaches can be very powerful in 6
detecting DMRs under specific scenarios (notably, DSS with r = 1 and BSmooth with Δmeth = 20%), their 7 performance can vary (and drop) significantly for different choices of the parameters tested in our 8 simulations (at least within the parameter-space considered here). In contrast, we show that, on the 9 whole, ABBA is the best performing method across a large number of parameters' combination tested and 10 accurately identifies DMRs in the large majority of simulated cases (Fig. 2c) . Specifically, ABBA's 11 performance was the highest in the detection of biologically meaningful changes in DNA methylation 12 (Δmeth ≥ 30%) and when little or no errors due to random switching of methylation status of CpG sites 13 between the two groups are present in the data. 14
DNA methylation is emerging as a major contributing factor in several human disorders (Zoghbi and 15
Beaudet 2016), including important autoimmune diseases like systemic lupus erythematosus (SLE) (Wu 16 et al. 2016) . For instance, differential DNA methylation analysis in CD4+ T cells in lupus patients 17 compared to normal healthy controls identified several genes with known involvement in autoimmunity 18 (Jeffries et al. 2011) . Here, to illustrate the practical utility of ABBA for differential methylation analysis in 19 disease, we generated WGBS data in an established experimental rat model of crescentic 20 glomerulonephritis (CRGN) (Aitman et al. 2006 ). In this model, we and others have previously shown that 21 susceptibility to CRGN is mediated by macrophages (Behmoaras et al. 2008; Page et al. 2012) ; therefore, 22
we assayed CpG methylation at single-nucleotide resolution by WGBS in primary macrophages derived 23 from Wistar Kyoto (WKY) and Lewis (LEW) isogenic rats (two strains discordant for their predisposition 24 to develop CRGN). We used ABBA to carry out genome-wide differential DNA methylation analysis in 25 primary bone-marrow derived macrophages (BMDM) derived from the disease-prone rat strain (WKY, r = 26 4) and control strain (LEW, r = 4) -see Methods for additional details on WGBS data generation and 27 processing. Briefly, in our ABBA analysis of the macrophage methylome, we used the following (default) 28 settings: a minimum of 5 CpG and at least 33% difference in DNA methylation between the disease and 29 control macrophages to identify DMRs. This choice was motivated and supported by data on the local 30 topology of CpG sites in the methylome showing the vast majority of the CpG clusters are in the range of 31 1-11 CpGs (Lövkvist et al. 2016 ) and to increase true positive rate in our DM analysis, following previous 1 assessment and recommendations for methylation analysis using WGBS data (Ziller et al. 2015) . 2
Using an FDR cutoff of 5%, ABBA identified 1,004 DMRs genome-wide, with 1.07% falling within an 3 annotated CpGI and 6.78% within an annotated CpGS (Fig. 3a) . For comparative purposes we also used 4 DSS (since this method performed very similarly to ABBA in several simulated cases, Fig. 2 ) to identify 5
DMRs genome-wide, which resulted in only 207 regions with significant differential methylation 6 (uncorrected p-value threshold = 10 -3 , using the default parameters of DSS). Of the 1,004 DMRs identified 7 by ABBA, 427 overlapped with annotated genes (Supplementary Table 3) , and there was a significant 2012) ( Fig. 3c) . For comparison, the 207 DMRs identified by DSS overlapped with 45 genes 13
( Supplementary Table 4 ), which were enriched only for RNA degradation and metabolic pathways. The Figure 10b-e) . The genes 20 identified by DSS when a window of 50 bp is used showed no significant enrichment for pathways, while 21 the results obtained for 100 bp and 1,000 bp windows showed a significant enrichment for RNA 22 degradation. These analyses highlight how the arbitrary choice of parameters related to the degree of 23 smoothing can affect greatly the results of a genome-wide DM analysis as well as the downstream 24 annotation of the genes overlapping with DMRs. In contrast, ABBA automatically adapts to different 25 correlation structures in DNA methylation levels across the genome without requiring any user-defined 26 parameters related to the smoothing procedure. 27
Figure 10a) and have varying distributions of DMR lengths (Supplementary
As DNA methylation can affect gene expression by interfering with transcription factor binding, we 28 performed a transcription factor binding site (TFBS) analysis of the DMRs (Fig. 3d) . the changes in DNA methylation identified by ABBA, we carried out differential expression (DE) analysis 1 in macrophages from WKY and LEW rats by RNA-seq (see Methods for details). The list of DE genes 2 (n=910, Benjamini-Hochberg (BH)-corrected p-value<0.05) was crosschecked with the genes impacted by 3 DMRs (above), identifying 48 genes with both significant differential methylation and differential 4 expression ( Supplementary Table 5 ). We observed the "textbook" model describing DNA methylation 5 regulating transcription via the promoter region (i.e., hypermethylation in the promoter associated with 6 transcriptional repression, see below) as well as widespread methylation changes in the genes body and 7
3'UTR associated with both gene repression and activation. The genes with concordant promoter 8 hypermethylation and transcriptional repression, Ifitm3, Ydjc and Cd300Ig were investigated in more 9 detail since the gene's promoter is a key regulatory region where the effect of DNA methylation is more 10 clearly understood. We found the biggest change in mRNA expression was in interferon induced 11 transmembrane protein 3 (Ifitm3), with mRNA from this gene being almost undetected in unstimulated 12 WKY macrophages (Fig. 3e) . This observation is consistent with the differential methylation status of the 13 promoter of Ifitm3, where the WKY rats had higher levels of methylation than the LEW rats (Fig. 3f) . To 14 further support the identification of differential methylation at the Ifitm3 gene we checked whether other 15 methods identified the same DMR. While MethylSig failed to identify significant DMR and BSmooth 16
identified a large and unspecific genomic area as differentially methylated, DSS provides highly consistent 17 results with ABBA, identifying differential methylation at the same region at the Ifitm3 gene promoter 18 Figure 11) . 19 We have previously shown that JunD (AP-1) transcription factor is a major determinant of CRGN in 20 WKY rats (Behmoaras et al. 2008 ) and others have shown that AP-1 is methylation sensitive (Ogawa et al. 21 2014 ). Therefore we scanned the DMR (spanning 600 bp) for canonical JunD binding site motifs, and 22
(Supplementary
identified three putative regions in the promoter region of Ifitm3 (Fig. 3g) . In addition, we re-analyzed 23
ChIP-seq data for JunD transcription factor in BMDM derived from WKY and a congenic strain from LEW 24 (see Methods for details). This analysis identified significant differences in JunD binding between WKY 25
and LEW-congenic strain that overlapped with two of the four TFBS identified at the Ifitm3 promoter ( Fig.  26   3g) . The combined evidence provided by our ABBA analysis and RNA-seq/ChIP-seq data therefore 27
suggests that the effect of DNA methylation of the Ifitm3 gene promoter in WKY rats (prone to develop 28 CRGN) may be restricting the binding of transcription factors such as JunD and, as a consequence, the gene 29 is almost not expressed (<1 TPM) in unstimulated macrophages of WKY rats. 30
DISCUSSION 1
As the cost of genome sequencing technologies continues to drop, it will soon become commonplace to 2 perform comprehensive methylome analyses, using WGBS or other high-throughput techniques that allow 3 the unbiased genome-wide quantification of DNA methylation at a single base-pair resolution. However, 4
high-resolution data generation is only the first step towards the identification of genomic loci and 5 eventually genes with altered methylation levels associated with a given disease, phenotype or 6 developmental stage. The number of DNA methylation datasets available in the public domain is expected 7 to grow; therefore, it becomes necessary to provide the scientific community with analytical tools for a 8 reliable and reproducible identification of differential methylation, and facilitate large epigenome-9 mapping projects and epigenome-wide association studies (Bock 2012) . accurately changes in DNA methylation localized to specific genomic loci (genes) is also influenced by 13 multiple factors inherently correlated to data quality. These include the within-group heterogeneity, the 14 level of noise, the presence of known genetic covariates (Zhang, 2015) and non-genetic confounding 15
factors (e.g., batch effects) as well as features such as sequencing depth (Ziller et al. 2015) or errors due 16 incomplete bisulphite conversion (Genereux et al. 2008) . Therefore, any analytical tool that can account 17 for all these factors will reduce the number of false positives maximizing the sensitivity and call the 18 regions of interest (i.e., differentially methylated) as accurately as possible. With this in mind, we designed 19 a differential methylation analysis tool (ABBA) that is robust to different experimental and technical 20 variables (see Fig. 2 ), and that adapts automatically to the varying genomic context and local topology of 21
CpG sites affecting methylation levels. In particular, the automatic adaptation to different correlation 22 structures in CpG methylation levels (without requiring user-defined parameters about the degree of 23 smoothing) as well as the ability of modelling its decay as the function of the genomic distances between 24
CpGs allow ABBA to adapt routinely to methylation changes that occurs with different scales and non-25 uniform rates across the genome. The importance of the genomic context in the methylome and the local 26 From a user's perspective, ABBA treats WGBS-seq data in a general way with no specification of 29 parameters related to the level of data smoothing (such as window size or kernel bandwidth), thus 30 allowing for a great deal of automation. This also facilitates the WGBS analysis when the values of the 31 parameter settings (that may largely affect the accuracy of DM identification) are not known. Our fully 1
Bayesian approach can be also easily modified to include covariates and non-genetic confounding factors 2 through random effects, beyond the replicates level. It also allows the specification of covariates that are 3 informative about the methylation profiles by adding prior biological information to the linear predictor Our extensive simulation studies ( Fig. 2) and differential DNA methylation analysis in 10 glomerulonephritis ( Fig. 3) showed that ABBA is a powerful approach for the identification of DMRs from 11 DNA methylation associated with disease. In this, we employed ABBA to analyze ~15 million CpG sites 21 genome-wide in primary bone-marrow derived macrophages derived from WKY and LEW rats and 22 identified >1,000 significant DMRs at 5% FDR level. A comparative analysis using DSS (the most 23 competitive approach from our simulation study) did not provide the same level of biological insight both 24 in terms of significant pathway enrichments and in robustly identifying DMRs across user-defined 25 parameters. To highlight this point, we showed how the results of DSS were greatly affected by the choice 26 of the window size. 27
Furthermore, we have shown how integrating the DMR results provided by ABBA with other 'omics' 28 data (RNA-seq and ChIP-seq generated in the same experimental system), enabled us to generate new 29 hypotheses for the mechanism underpinning the disease, revealing a candidate gene (Ifitm3) for the 30 susceptibility to glomerulonephritis. These findings on Ifitm3 in rat glomerulonephritis merit further 31 discussion. Ifitim3 has a known role in viral resistance, a central part of innate immunity, and is inducible 32 by both interferon (IFN) types I and II (Everitt et al. 2012) . Notably, type II IFN signaling has been 1 implicated in the pathogenesis of nephrotoxic nephritis and other "planted" antigen models of CRGN 2 (Kitching et al. 2004 ), although DNA methylation has not previously been examined in this context. With 3 regards to type I IFN, recent genome-wide DNA methylation analysis of T-cells, B-cells and monocytes has 4
shown that patients with SLE, a frequent autoimmune cause of CRGN, have severe hypomethylation near 5
to genes involved in type I IFN signaling (Absher et al. 2013 ). In addition, DNA methylation alterations in 6 IFN-related genes, including Ifitm3, have been previously observed and proposed to contribute to the 7 pathogenesis of other autoimmune diseases such as primary Sjögren's syndrome (Gottenberg et al. 2006 ). 8
Regarding the role of Ifitm3 gene, it has been shown to directly interact in vivo and in vitro, with 9 osteopontin, a matricellular protein, whose transcription is mediated by the AP-1 TF family (El-Tanani et In a wider context, the role of methylation is dependent on the location with respect to the gene body 18 and regulation functions. Methylation in a CpGI-depleted promoter, such as the promoter region of Ifitm3 19 gene (according to UCSC genome browser (RN4)), is associated with repression that maybe due to 20 interference with transcription factor binding. Conversely, methylation in the gene body is positively 21 associated with active transcription as methylation can be caused by transcriptional elongation 22 (Schübeler 2015) . Methylation within a gene body can also act as an insulator for repetitive and 23 transposable elements or distal intronic enhancers, on which the methylation would have no regulatory 24 effect on the gene in which it resides (Jones 2012) . Given the complexity of these regulatory functions of 25 methylation, the ability of our approach to accurately identify changes in DNA methylation that are 26 localized to specific regions is likely to facilitate our understanding of the complex relationships between 27 methylation and gene regulation. As exemplified by our integrative analysis of the of the Ifitm3 locus, we 28 anticipate that the ABBA results for differential DNA methylation should be integrated with additional 29 transcriptional and epigenetic data in order to better define hypotheses on specific regulatory 30
mechanisms. 31
In summary, we show how ABBA provides a flexible and user-friendly automatic framework for the 1 identification of differential methylation that is robust across a wide range of experimental parameters, an 2 approach that we have also applied to identify changes in macrophage DNA methylation in 3 glomerulonephritis. CpG of 30x, δ = 10%. For each of this combination of parameters, the corresponding best method based 6 on its pAUC is indicated in the benchmark grid below. In (i) and (iv) ROC curves are reported only for the 7 methods that can analyze WGBS data generated from one biological sample. (b) Global snapshot of the 8 method's performance across 216 simulated datasets. A given combination of parameters is indicated by a 9 square in the benchmark grid, and for each square we calculated the pAUC for each method and 10 determined which method had the overall best pAUC (i.e., pAUCmethod_1 > pAUCmethod_2). Colours in the 11 benchmark grid indicate which method had the best performance. When pAUC of two methods are similar 12 (±1%) we report the colours of both methods (e.g., black and red colours in the same square indicate 13 similar performance of ABBA and DSS). The six selected combination of parameters for which the ROC 14 curves are reported in panel (a) are indicated within the benchmark grid: (i, ii, iii, iv, v and vi). All ROC 15 curves are reported in Supplementary Figures 5-7. (c) For the three best performing methods (ABBA, 16
DSS and BSmooth) we report the percentage of simulated scenarios in which each method resulted to be 17 the best based on the pAUC comparison. "Tie" indicates the proportion of simulated scenarios in which the 18 pAUCs of any two methods were similar (i.e., pAUCs ±1%) and it was not possible to single out a single 19 best performing approach. overlapped with two (out of four) JunD binding sites motifs identified within the gene promoter (±500bp 1 around the TSS). ABBA DMR, differentially methylated region identified by ABBA. TSS, transcription start 2 site. *, p-value<0.05, ***, p-value<0.001 3 4
